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q Cell-surface expression of CD4 
reduces HIV-1 infectivity by 
blocking Env incorporation in a 
Nef- and Vpu-inhibitable 
manner. 
Juan Lama, Aram Mangasarian and 
Didier Trono (1999). Curr. Biol. 
9,622-631. 
HIV-1 infection decreases the cell- 
surface expression of its cellular 
receptor, CD4, through the combined 
actions of three viral proteins: Nef, Env 
(envelope) and Vpu. Such functional 
convergence strongly suggests that CD4 
downregulation is essential for optimal 
viral replication, but the significance of 
this phenomenon has so far remained a 
mystery. The authors show that high 
levels of CD4 on the surface of 
HIV-infected cells induce a dramatic 
reduction in the infectivity of released 
virions by the sequestering of the viral 
envelope by CD4. CD4 is able to 
accumulate in viral particles while at the 
same time blocking incorporation of 
Env into the virion. Nef and Vpu, 
through their ability to downregulate 
CD4, counteract this effect. The 
CD4-mediated ‘envelope interference’ 
probably explains why HIV has 
developed more than one mechanism to 
downregulate the cell-surface 
expression of its receptor. 
3 June 1999, Research Paper, 
Current Biology. 
0 A new member of the 
endonuclease III family of DNA 
repair enzymes that removes 
methylated purines from DNA. 
Thomas J Begley, Brian J Haas, Jerry 
Noel, Alexander Shekhtman, William 
A Williams and Richard P 
Cunningham (1999). Curr. Biol. 
9,653-656. 
DNA is constantly exposed to 
endogenous and exogenous alkylating 
agents that can modify its bases, resulting 
in mutagenesis in the absence of DNA 
repair. DNA glycosylases remove 
alkylation damage by initiating the base- 
excision repair pathway and protecting 
the sequence information of the genome. 
The authors have identified a new class 
of methylpurine DNA glycosylase, 
designated MpgII, that is a member of 
the endonuclease III family of DNA 
repair enzymes. The authors showed that 
the enzyme releases both 7- 
methylguanine and 3-methyladenine 
from DNA. The Mpg11 genes from 
T maritima and Aquzlifex aeolicus could 
restore methylmethanesulfonate (MMS) 
resistance to Eschedia cob alkA tagA 
double mutants, which are deficient in 
the repair of alkylated bases. Mpg11 is 
the fifth member of the endonuclease III 
family of DNA repair enzymes, 
suggesting that the endonuclease III 
protein scaffold has been modified 
during evolution to recognize and repair 
a variety of DNA damage. 
7 June 1999, Brief Communication, 
Current Biology. 
0 Crystal structure of mammalian 
purple acid phosphatase. 
Luke W Guddat, Alan S McAlpine, 
David Hume, Susan Hamilton, John 
de Jersey and Jennifer L Martin 
(1999). Structure 7, 757-768. 
Mammalian purple acid phosphatases 
are highly conserved binuclear metal- 
containing enzymes produced by 
osteoclasts, the cells that resorb bone. 
There is strong evidence that the 
enzyme is involved in bone resorption, 
so it is a target for drug design. The 
structure of pig purple acid phosphatase 
has been solved. Despite less than 15% 
sequence identity, the protein fold 
resembles that of the catalytic domain of 
plant purple acid phosphatase and some 
serine/threonine protein phosphatases. 
The active-site regions of the 
mammalian and plant purple acid 
phosphatases differ significantly, 
however. The internal symmetry 
suggests that the binuclear centre 
evolved as a result of the combination of 
mononuclear ancestors. The structure of 
the mammalian enzyme provides a basis 
for the design of drugs for bone 
resorptive diseases. 
22 June 1999, Research Paper, 
Structure. 
0 Design of allosteric 
hammerhead ribozymes 
activated by ligand-induced 
structure stabilization. 
Garrett A Soukup and Ronald R 
Breaker (1999). Structure 
7, 783-791. 
Ribozymes can function as allosteric 
enzymes that undergo a conformational 
change upon ligand binding to a site 
other than the active site. Although 
allosteric ribozymes are not known to 
exist in nature, modular rational design 
has been used to engineer artificial 
ribozymes that act as allosteric 
enzymes. In this study, the authors 
exploit the modular nature of certain 
functional RNAs to engineer allosteric 
ribozymes that are activated by flavin 
mononucleotide (FMN) or 
